Endocannabinoids in the central nervous system--an overview.
about
The orphan receptor GPR55 is a novel cannabinoid receptorEffects of Neuroendocrine CB1 Activity on Adult Leydig CellsCannabinoid and opioid interactions: implications for opiate dependence and withdrawalThe role of sex steroid hormones, cytokines and the endocannabinoid system in female fertilityBehavioral sequelae following acute diisopropylfluorophosphate intoxication in rats: comparative effects of atropine and cannabinomimeticsObesity: Current and potential pharmacotherapeutics and targets.Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke.Pharmacology of signaling induced by dopamine D(1)-like receptor activationThe endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damageInvolvement of cannabinoid receptors in gut motility and visceral perception.Overlapping and interactive pathways regulating appetite and craving.The intracerebroventricular injection of rimonabant inhibits systemic lipopolysaccharide-induced lung inflammation.Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamateDrug design for neuropathic pain regulation from traditional Chinese medicineN-Palmitoylethanolamine Prevents the Run-down of Amplitudes in Cortical Spreading Depression Possibly Implicating Proinflammatory Cytokine Release.Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.Unconventional neurotransmitters, neurodegeneration and neuroprotection.Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.A case for neuroprotection in ophthalmology: developments in translational research.Review: The neuropathology of drug abuse.Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3.Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana.Polyunsaturated fatty acids and endocannabinoids in health and disease.Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation.Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females.Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians.Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain.Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin.Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina.Synthesis of a photoactivatable probe of the anandamide re-uptake.Effects of N-acylethanolamines on the respiratory chain and production of reactive oxygen species in heart mitochondria.Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.The correlation of anandamide with gonadotrophin and sex steroid hormones during the menstrual cycle.Interactions of β-lactoglobulin with serotonin and arachidonyl serotonin.In vitro effects of anandamide and prostamide e2 on normal and transformed nerve cells.Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats.
P2860
Q24670137-9390F640-DC70-4965-BDA9-89A689C44ECBQ26745178-BDA5B7FC-2F94-4149-96EF-ABB26A6C3374Q27000762-1FD5621A-D9FC-477C-BE20-119E09827BD0Q28303095-119F4A45-476E-4F3D-929C-F21F973CEDF1Q28394730-18CFAAD3-1019-46AB-B790-63D740999F44Q30243992-FF217A9C-789C-4163-9DBE-AD826A157B29Q33697608-7D8F43B0-23A6-46A8-91AB-664435B01C30Q34126949-CC16DB67-ECD2-4096-A456-1E9709B57912Q34587990-038103C9-A5F6-4E4F-84C0-7E8C9814530DQ35103574-B65E0F5B-17B5-4AF2-92B8-8D3B380EACF4Q35546025-2598A81F-8E25-41B3-94B6-1E2937BB7AEFQ35752224-6A0CDBCA-5CF2-432F-BBF5-9ECBF9557EDBQ35837863-F99736E8-944E-4FE8-9C2E-68320BA676FFQ35992908-CD5B25EE-B79B-4146-8E54-251E0080DF65Q36358712-FCFE164B-5896-4B1A-8BAC-0673D3A32556Q36572904-F04DB492-E989-465B-8066-3A9CC918D4B3Q36719358-EF9DE562-4506-4782-A057-8C780ABAB933Q37143586-482B0A32-66E9-4495-BDA5-BCFFD77A0875Q37393806-0076A038-F2AD-4A1C-AFF6-8228BF969DC7Q37645117-D9915A52-299B-4477-AAB9-D32BD2CA5EDDQ37680649-6431622C-73CF-4EB0-B7ED-3069F592E763Q37800120-7E45290B-6CE2-435B-80D4-551FE4B50F51Q38358196-7BFC143E-57A1-4D6F-88BD-207AC0FD9CA2Q38735357-2E84CA5F-967B-4F67-BFCF-EED83E19E8BAQ39421016-0053A065-B9F8-4CD1-A56F-DBF85FB50D7EQ40006174-F4737314-6F9C-4681-A6F6-107D9D561DBDQ40469664-F249E38B-94A8-4DA6-8DBB-9BAF1CCCAF44Q43197088-3305849D-3557-4DBD-B161-56B09AAE425DQ43537622-E454B5D2-6FB0-4AB2-ACFF-459AE129F66AQ44345303-45E9D5F4-0878-4BB2-B28F-D9D21A42C68BQ44473677-4DE4AA85-04A2-4B1A-BC96-9B1D1E705EBDQ46421589-28E7D121-44C7-4912-B51D-8FBE97753608Q46447396-B83D6CC8-77DE-45A0-B89D-8CCCA5E0E042Q46529908-606DFAD7-DCE9-4B8B-BE1D-C1BDE2F4AF4FQ46649595-6063467B-1834-4B8A-8246-D6B1B731600DQ46936833-1C64A385-0CD5-47CA-AB11-7BD6DF25F58AQ47162977-AC94B67F-DEF6-41B5-83EC-4794F096C5BCQ48294338-0C058E81-EEBF-4C7C-9E26-0C48198677B9Q48600669-88A310EA-8FFA-4C82-980C-A6512661362DQ50460043-00794168-BBCD-4422-9374-09B8C2F1AC09
P2860
Endocannabinoids in the central nervous system--an overview.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Endocannabinoids in the central nervous system--an overview.
@ast
Endocannabinoids in the central nervous system--an overview.
@en
Endocannabinoids in the central nervous system--an overview.
@nl
type
label
Endocannabinoids in the central nervous system--an overview.
@ast
Endocannabinoids in the central nervous system--an overview.
@en
Endocannabinoids in the central nervous system--an overview.
@nl
prefLabel
Endocannabinoids in the central nervous system--an overview.
@ast
Endocannabinoids in the central nervous system--an overview.
@en
Endocannabinoids in the central nervous system--an overview.
@nl
P356
P1476
Endocannabinoids in the central nervous system--an overview.
@en
P2093
P304
P356
10.1054/PLEF.2001.0360
P577
2002-02-01T00:00:00Z